Neo Elite for Melasma Treatment: Targeting Pigment at the Dermal & Epidermal Level | IMCAS 2026
Watch Dr. Maris Garori demonstrate a live Neo Elite melasma treatment at IMCAS 2026, highlighting how its 650-microsecond pulse safely targets pigment across all skin types.
At IMCAS 2026 in Paris, France, dermatologist Dr. Maris Garori walks through a live Neo Elite treatment on a melasma patient demonstrating how the device's 650-microsecond 1064nm Nd:YAG technology addresses one of dermatology's most treatment-resistant pigment disorders.
Dr. Garori explains why melasma presents a unique challenge: as both a dermal and epidermal condition with an underlying inflammatory component, most lasers are too aggressive and risk worsening pigmentation. The Neo Elite's ultra-short pulse duration and 1064nm wavelength allow clinicians to selectively target melanin and reduce inflammation without disrupting surrounding tissue — making it one of the few laser systems capable of safely treating melasma across all Fitzpatrick skin types.
She also discusses the broader clinical reality many patients face: skin conditions rarely present in isolation. Patients may be managing inflammation, acne, barrier damage, vascular instability, and pigment disorders simultaneously — sometimes all at once. The Neo Elite's ability to precisely deliver energy without collateral thermal damage makes it uniquely suited to address this complexity without compromising safety or outcomes.
Presented by Maris Garori, MD
Dr. Maris Garori, MD, MSc is an aesthetic physician and aesthetic surgeon based in Albania and Italy, and owner of Derm-X Aesthetic Medical Clinic in Tirana. She earned her medical degree from the Università degli Studi di Padova and holds an MSc alongside additional training in cosmetic dermatology, aesthetic medicine, regenerative medicine, and morpho-functional surgery. Dr. Garori is an active contributor to the international aesthetic medicine community, having presented research at leading congresses including AMWC Monaco and the 5 Continents Congress. Her clinical work includes expertise in laser-based treatments — notably the use of 650-microsecond Nd:YAG 1064nm technology in the treatment of melasma — as well as a broader focus on regenerative and anti-aging approaches to skin care.

